Financial Performance - Rental revenues for the nine months ended September 30, 2024, reached 86,570,000,a16.574,325,000 for the same period in 2023[7] - Net income attributable to common stockholders for the nine months ended September 30, 2024, was 2,628,000,comparedto1,782,000 for the same period in 2023, reflecting a 47.5% increase[7] - The company reported a comprehensive income attributable to common stockholders of 2,628,000fortheninemonthsendedSeptember30,2024,comparedto1,782,000 for the same period in 2023[7] - For the nine months ended September 30, 2024, net cash provided by operating activities was 34,525,000,comparedto42,006,000 for the same period in 2023[10] - The company reported net bonds, notes payable, and other debt of 579,629,000asofSeptember30,2024,upfrom536,486,000 as of December 31, 2023, reflecting an increase of approximately 8%[77] - The company’s gross bonds, notes payable, and other debt totaled 584,508,000asofSeptember30,2024,comparedto539,145,000 as of December 31, 2023, indicating a rise of about 8.4%[77] - Total expenses for Q3 2024 were 13.4million,up5.712.7 million in Q3 2023, with notable increases in depreciation (9.2%) and amortization (59.4%)[187] - General and administrative expenses increased by 1.1millionor27.4661,545,000 as of September 30, 2024, up from 616,795,000onDecember31,2023,representingagrowthof7.5606,326,000 as of September 30, 2024, compared to 569,522,000attheendof2023,indicatinga6.523,286,000 as of September 30, 2024, from 8,604,000attheendof2023,asignificantincreaseof171.555,219,000 as of September 30, 2024, up from 47,273,000attheendof2023,reflectingagrowthof16.553.2 million as of September 30, 2024, with the ability to offer an additional 350millioninbondssubjecttomarketconditions[196]CashFlowandInvestments−Cashusedininvestingactivitiestotaled43,010,000 for the nine months ended September 30, 2024, compared to 113,550,000inthesameperiodofthepreviousyear[10]−ThenetincreaseincashandcashequivalentsfortheninemonthsendedSeptember30,2024,was15.5 million, contrasting with a decrease of 10.7millionin2023[203]−Cashandcashequivalentsattheendoftheperiodfor2024were53.2 million, up from 35.0millionin2023,markinganincreaseofapproximately52.166 million, with an interest rate of 8.42% as of September 30, 2024[81] - The Series A Bonds had an outstanding balance of 49.7millionasofSeptember30,2024,withaninterestrateof6.9755.4 million as of September 30, 2024, with an initial interest rate of 5.7% per annum[97][98] - The company has committed to not pledge its assets under general liens without prior consent from bondholders[92] - The company’s financial covenants require that consolidated equity not be less than 20millionandthattheratioofindebtednesstoEBITDAnotexceed10[88][101]PropertyandOperations−TheCompanyownsapproximately14.287.5 million, with the closing anticipated before year-end 2024[159] Rental Income and Revenue - The Company received rental income from related parties amounting to 53.2millionfortheninemonthsendedSeptember30,2024,comparedto40.6 million for the same period in 2023, representing a 31.8% increase[150] - Total future minimum rental revenues for the company's tenants are projected to be 733,212,000,with25,068,000 expected in the three-month period of 2024[72] - Rental revenues increased by 3.7millionor14.325.8 million in Q3 2023 to 29.5millioninQ32024,drivenbyhigherincomefromadditionalpropertiesandleaserenewals[187]DepreciationandAmortization−Thecompanyreportedadepreciationandamortizationexpenseof24,666,000 for September 2024, up from 21,266,000inSeptember2023[10]−TheincreaseindepreciationandamortizationfortheninemonthsendedSeptember30,2024,was3.4 million or 16.0%, primarily due to new property purchases[190] - Depreciation and amortization expenses for the nine months ended September 30, 2024, were 24.7million,comparedto21.3 million in 2023, indicating an increase of about 16.0%[204] Compliance and Risk - The company was in compliance with all financial covenants as of September 30, 2024, including a debt service coverage ratio (DSCR) requirement of at least 1.05[82] - The company is subject to market concentration risk, with significant revenue generated from Medicare and Medicaid, making it vulnerable to regulatory changes[40] - The Company has potential exposure to claims for fraud and breach of contract related to post-closing obligations, but believes these claims are without merit[136]